osaterone acetate has been researched along with dihydrotestosterone in 4 studies
| Studies (osaterone acetate) | Trials (osaterone acetate) | Recent Studies (post-2010) (osaterone acetate) | Studies (dihydrotestosterone) | Trials (dihydrotestosterone) | Recent Studies (post-2010) (dihydrotestosterone) |
|---|---|---|---|---|---|
| 32 | 5 | 3 | 9,325 | 307 | 1,517 |
| Protein | Taxonomy | osaterone acetate (IC50) | dihydrotestosterone (IC50) |
|---|---|---|---|
| Plasma kallikrein | Homo sapiens (human) | 0.0031 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.54 | |
| Sex hormone-binding globulin | Homo sapiens (human) | 0.0038 | |
| Progesterone receptor | Oryctolagus cuniculus (rabbit) | 0.44 | |
| Progesterone receptor | Homo sapiens (human) | 7.3 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.36 | |
| Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | 0.023 | |
| Androgen receptor | Homo sapiens (human) | 0.0048 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.4041 | |
| Androgen receptor | Mus musculus (house mouse) | 0.001 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 2.1 | |
| Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukabori, Y; Hamataki, N; Honma, S; Kushitani, M; Mieda, M; Takezawa, Y; Yamanaka, H | 1 |
| Fukabori, Y; Hamataki, N; Honma, S; Ito, K; Kushitani, M; Mieda, M; Suzuki, K; Takezawa, Y; Yamanaka, H | 1 |
| Akimoto, S; Ichikawa, T; Shimazaki, J | 1 |
| Fukabori, Y; Honma, S; Minato, K; Suzuki, K; Takezawa, Y; Yamanaka, H | 1 |
4 other study(ies) available for osaterone acetate and dihydrotestosterone
| Article | Year |
|---|---|
Effects of the new steroidal antiandrogen TZP-4238 on hormone-induced canine prostatic hyperplasia.
Topics: Androstane-3,17-diol; Animals; Chlormadinone Acetate; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Dogs; Male; Organ Size; Oxidoreductases; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Ultrasonography | 1992 |
Effects of a new steroidal antiandrogen, TZP-4238 (17 alpha-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Animals; Chlormadinone Acetate; Contraceptives, Oral; Dihydrotestosterone; Disease Models, Animal; Dogs; Male; Organ Size; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Testosterone; Ultrasonography | 1995 |
An inhibitory effect of TZP-4238 on the growth of androgen-sensitive rat prostatic tumor (Dunning R3327).
Topics: Administration, Oral; Androgen Antagonists; Androgens; Animals; Chlormadinone Acetate; Dihydrotestosterone; Male; Neoplasms, Hormone-Dependent; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Testis; Testosterone | 1993 |
[Effects of antiandrogen TZP-4238 on the prostatic androgen receptor and prostatic androgen in rat].
Topics: Androgen Antagonists; Androgens; Animals; Chlormadinone Acetate; Cyproterone; Dihydrotestosterone; Male; Prostate; Rats; Receptors, Androgen; Testosterone | 1994 |